Harriet de Wit
Professor of Psychiatry at the University of Chicago
Data updated
Research Footprint
Harriet de Wit appears in 32 tracked papers (2010–2026), most studied alongside MDMA, LSD and Placebo, across Healthy Volunteers, Interpersonal Functioning & Social Connectedness and Microdosing.
Most-cited paper: Is Ecstasy an “Empathogen”? Effects of ±3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others (245 citations).
Frequent co-authors: Anya Bershad, Richard Lee and Matthew Kirkpatrick.
Background & Research
Dr. Harriet de Wit is the Director of the Human Behavioral Pharmacology Laboratory at the University of Chicago. Her extensive research focuses on the physiological, subjective, and behavioral effects of drugs in healthy human volunteers. In the psychedelic field, she investigates individual differences in response to LSD and MDMA, aiming to understand the underlying mechanisms of motivated behavior and drug-induced mood changes.
Key Impact
A pioneer in human behavioral pharmacology with over 40 years of research on the effects of psychoactive drugs.
Collaboration Network
13 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Top Collaborators
Affiliations
Institutions, companies, and organisations Harriet de Wit is associated with.